claire_thom_astellas

Astellas hires senior VP from rival Takeda

pharmafile | August 15, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  Astellas, Takeda, oncology 

Astellas has appointed Claire Thom from fellow Japanese firm Takeda to be senior vice president of its global oncology development.

Thom will report to chief medical officer Sef Kurstjens at Astellas, and will replace Dr Wayne Klohs who recently retired.

“We ‘re thrilled that Claire is joining our experienced oncology team at Astellas,” said Kurstjens. “We believe that her unique background and varied experience, along with her approach to leadership and management will support our mission to become a global category leader in oncology. “

Advertisement

Thom has more than 24 years of experience in the pharma industry across a wide range of functional areas including drug development, new product planning and marketing.

Most recently she served as senior VP Portfolio Management, Drug Development Management and Strategic Business Operations at Millennium: The Takeda Oncology Company. 

Related Content

Von Willebrand disease – increasing awareness and access to vital care

Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about …

Rethinking oncology trial endpoints with generalised pairwise comparisons

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival …

drug-trials

Pharma&’s ovarian cancer therapy approved for use by NHS Scotland

Pharma& has announced that its treatment for ovarian cancer, Rubraca (rucaparib), has been accepted by …

The Gateway to Local Adoption Series

Latest content